Highly Sensitive Electrochemical Aptasensor for Detecting the VEGF(165) Tumor Marker with PANI/CNT Nanocomposites
Sensing targeted tumor markers with high sensitivity provides vital information for the fast diagnosis and treatment of cancer patients. A vascular endothelial growth factor (VEGF(165)) have recently emerged as a promising biomarker of tumor cells. The electrochemical aptasensor is a promising tool...
Gespeichert in:
Veröffentlicht in: | Biosensors (Basel) 2021-04, Vol.11 (4), Article 114 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Sensing targeted tumor markers with high sensitivity provides vital information for the fast diagnosis and treatment of cancer patients. A vascular endothelial growth factor (VEGF(165)) have recently emerged as a promising biomarker of tumor cells. The electrochemical aptasensor is a promising tool for detecting VEGF(165) because of its advantages such as a low cost and quantitative analysis. To produce a sensitive and stable sensor electrode, nanocomposites based on polyaniline (PANI) and carbon nanotube (CNT) have potential, as they provide for easy fabrication, simple synthesis, have a large surface area, and are suitable in biological environments. Here, a label-free electrochemical aptasensor based on nanocomposites of CNT and PANI was prepared for detecting VEGF(165) as a tumor marker. The nanocomposite was assembled with immobilized VEGF(165) aptamer as a highly sensitive VEGF(165) sensor. It exhibited stable and wide linear detection ranges from 0.5 pg/mL to 1 mu g/mL, with a limit of detection of 0.4 pg/mL because of the complementary effect of PANI/CNT. The fabricated aptasensor also exhibited good stability in biological conditions, selectivity, and reproducibility after several measurement times after the dissociation process. Thus, it could be applied for the non-invasive determination of VEGF, in biological fluid diagnosis kits, or in an aptamer-based biosensor platform in the near future. |
---|---|
ISSN: | 2079-6374 |
DOI: | 10.3390/bios11040114 |